Trial Profile
An open label, prospective, randomized, controlled, multicenter study assessing fixed dose vs. concentration controlled CellCept [mycophenolate mofetil] regimens for patients following a single organ renal tranplantation in combination with full dose and reduced dose calcineurin inhibitors
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2010
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Ciclosporin; Corticosteroids; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 29 Sep 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 15 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2009 Actual initiation date (Jan 2008) added as reported by ClinicalTrials.gov.